Company research
IMPACT BIOMEDICAL INC.
CIK 1834105Updated Nov 19, 2026
Historical securities (1)
IBO · NYSE_AMERICAN · equity · closed Nov 17, 2026IBO price & chart
This listing closed Nov 17, 2026. Live provider charts are shown only for current listings.
In the news
CORRECTED — Impact Biomedical Inc (NYSE: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Limited (f/k/a Dr Ashleys Limited) ↗
Recent filings
Completion of Acquisition or Disposition of Assets · Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing · Material Modification to Rights of Security Holders · Changes in Control of Registrant · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Items 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 9.01
25-NSE - filed by NYSE AMERICAN LLC regarding IMPACT BIOMEDICAL INC.
Submission of Matters to a Vote of Security Holders
Items 5.07
10-Q filing
4 filing
Show 5 more recent filings
4 filing
4 filing
Regulation FD Disclosure
Items 7.01, 9.01
DEFM14A filing
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Items 5.03, 9.01
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 18,208,000Source | 46,695,000Source | 16,745,000Source | 19,060,000Source | 44,116,000Source | 17,086,000Source | 20,051,000Source | 44,356,000Source | 17,405,000Source | 20,290,000Source | 44,633,000Source | 46,497,000Source |
| Property, Plant and Equipment, NetUSD | 13,000Source | 282,000Source | — | 14,000Source | 284,000Source | — | 16,000Source | 285,000Source | — | 17,000Source | 287,000Source | 276,000Source |
| GoodwillUSD | — | 25,093,000Source | — | — | 25,093,000Source | — | — | 25,093,000Source | — | — | 25,093,000Source | 25,093,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 12,000Source | 2,668,000Source | — | 624,000Source | 2,000Source | 20,000Source | 1,318,000Source | 2,000Source | 3,000Source | 1,999,000Source | 1,000Source | 2,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 15,000Source | — | — | — | 128,000Source | — | 4,000Source | 128,000Source | 5,000Source | — | — | — |
| Inventory, NetUSD | 485,000Source | — | 62,000Source | 486,000Source | — | 63,000Source | 489,000Source | — | 63,000Source | — | — | — |
| Assets, CurrentUSD | 917,000Source | 3,175,000Source | 320,000Source | 1,481,000Source | 307,000Source | 377,000Source | 2,183,000Source | 335,000Source | 411,000Source | 2,448,000Source | 332,000Source | 122,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 206,000Source | 365,000Source | 51,000Source | 171,000Source | 42,000Source | 95,000Source | 172,000Source | 2,000Source | 142,000Source | 265,000Source | — | 104,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 27,061,000Source | 12,344,000Source | 2,733,000Source | 26,440,000Source | — | 2,375,000Source | 13,241,000Source | — | 1,850,000Source | 13,053,000Source | 16,371,000Source | 13,828,000Source |
| Stockholders’ equity: | ||||||||||||
| Preferred Stock, Value, IssuedUSD | 60,000Source | 60,000Source | — | 60,000Source | 60,000Source | — | 60,000Source | 60,000Source | — | 60,000Source | 60,000Source | — |
| Common Stock, Value, IssuedUSD | 12,000Source | 11,000Source | 108,000Source | 12,000Source | 10,000Source | 108,000Source | 12,000Source | 10,000Source | 105,000Source | 11,000Source | 10,000Source | 70,000Source |
| Additional Paid in CapitalUSD | 42,871,000Source | 41,838,000Source | 63,150,000Source | 42,870,000Source | 38,113,000Source | 63,150,000Source | 42,707,000Source | 38,113,000Source | 62,011,000Source | 41,857,000Source | — | — |
| Retained Earnings (Accumulated Deficit)USD | -54,752,000Source | -10,561,000Source | -52,492,000Source | -53,283,000Source | -14,810,000Source | -51,794,000Source | -38,936,000Source | -13,923,000Source | -49,507,000Source | -37,669,000Source | -12,961,000Source | -8,625,000Source |
| Stockholders' Equity Attributable to ParentUSD | -11,809,000Source | 31,348,000Source | 10,766,000Source | -10,341,000Source | 23,373,000Source | 11,464,000Source | 3,843,000Source | 24,260,000Source | 12,609,000Source | 4,259,000Source | 25,222,000Source | 29,558,000Source |
| Additional Paid in Capital, Common StockUSD | — | — | — | — | — | — | — | — | — | — | 38,113,000Source | 38,113,000Source |
| Liabilities and EquityUSD | 18,208,000Source | 46,695,000Source | 16,745,000Source | 19,060,000Source | 44,116,000Source | 17,086,000Source | 20,051,000Source | 44,356,000Source | 17,405,000Source | 20,290,000Source | 44,633,000Source | 46,497,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 23,793,000Source | 1,138,000Source | 2,045,000Source | 23,172,000Source | 14,499,000Source | 1,687,000Source | 9,973,000Source | 13,857,000Source | 1,162,000Source | 9,785,000Source | 13,136,000Source | 10,593,000Source |
| Accounts Payable, CurrentUSD | 576,000Source | 1,001,000Source | 467,000Source | 554,000Source | 986,000Source | 374,000Source | 615,000Source | 1,023,000Source | 347,000Source | 713,000Source | 832,000Source | 539,000Source |
| Deferred Income Tax Liabilities, NetUSD | 3,268,000Source | 3,235,000Source | 688,000Source | 3,268,000Source | 3,235,000Source | 688,000Source | 3,268,000Source | 3,235,000Source | 688,000Source | 3,268,000Source | 3,235,000Source | 3,235,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | 2,956,000Source | 3,003,000Source | 3,246,000Source | 2,961,000Source | 3,009,000Source | 3,247,000Source | 2,967,000Source | 3,004,000Source | 2,946,000Source | 2,978,000Source | 3,040,000Source | 3,111,000Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 336,000Source | 102,000Source | 248,000Source | 266,000Source | 61,000Source | 210,000Source | 217,000Source | 47,000Source | 194,000Source | 194,000Source | 230,000Source | 63,000Source |
| Deferred Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | 688,000Source | — | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | -1,475,000Source | 4,241,000Source | -700,000Source | -14,352,000Source | -2,284,000Source | -1,278,000Source | -11,870,000Source | -24,770,000Source | — | — |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | 285,000Source | 283,000Source | 1,145,000Source | 1,119,000Source | 1,120,000Source | 1,113,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 1,440,000Source | 2,000Source | 13,000Source | 19,000Source | — | — |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | -5,000Source | — | 1,000Source | — | — | — |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | — | — | -7,000Source | — | — | — |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | 27,000Source | -98,000Source | 470,000Source | -436,000Source | 293,000Source | 424,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | -2,580,000Source | 33,000Source | — | -621,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -464,000Source | -682,000Source | -1,890,000Source | -3,919,000Source | -2,851,000Source | -2,242,000Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -1,000Source | 1,000Source | 3,000Source | 2,000Source | -15,000Source | -349,000Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 482,000Source | — | -109,000Source | 5,915,000Source | 2,865,000Source | 2,547,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 17,000Source | -681,000Source | -1,996,000Source | 1,998,000Source | -1,000Source | -44,000Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | — | — | 0Source | 2,000Source | 1,440,000Source | — | 13,000Source | — | — | — |
| DepreciationUSD | — | — | — | — | — | — | — | 1,000Source | 6,000Source | 7,000Source | 6,000Source | 0Source |
| Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber PropertyUSD | — | — | — | — | — | — | — | — | -12,000Source | — | — | — |
| Gain (Loss) on Disposition of Intangible AssetsUSD | — | — | — | — | — | — | — | — | -12,000Source | — | — | — |
| GoodwillUSD | — | — | — | 25,093,000Source | — | — | — | — | — | — | 25,093,000Source | 25,093,000Source |
| Goodwill, Impairment LossUSD | — | — | — | 0Source | — | — | — | — | — | 25,093,000Source | 0Source | 0Source |
| Impairment of Intangible Assets, Finite-livedUSD | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source | 0Source |
| Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | -2,580,000Source | 33,000Source | — | -621,000Source |
| Investment Income, InterestUSD | — | — | — | — | 2,000Source | 3,000Source | 5,000Source | 3,000Source | — | — | 13,000Source | 24,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -1,470,000Source | 4,247,000Source | -699,000Source | -14,346,000Source | -2,287,000Source | -1,267,000Source | -11,838,000Source | -24,708,000Source | -4,407,000Source | -7,255,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | -5,000Source | -6,000Source | -1,000Source | -6,000Source | 3,000Source | -11,000Source | -32,000Source | -62,000Source | — | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | 4,247,000Source | — | — | — | — | — | — | -4,336,000Source | -7,051,000Source |
| Operating Costs and ExpensesUSD | — | — | 966,000Source | 1,127,000Source | 705,000Source | 1,160,000Source | 2,296,000Source | 1,010,000Source | 4,314,000Source | — | — | — |
| Operating ExpensesUSD | — | — | — | 1,127,000Source | — | — | — | 1,010,000Source | — | 28,753,000Source | — | — |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | — | — | — | 3,726,000Source | — | — |
| Amortization | — | — | — | — | — | — | — | — | — | — | — | — |
| Amortization of Intangible Assets | — | — | — | — | — | — | —Source | —Source | — | — | — | — |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | — | — | — | — | — | — | — | —Source | — | — | — | — |
| InterestExpenseNonoperating | — | — | — | — | — | —Source | — | —Source | — | — | — | — |
| Proceeds from Issuance of Long-term Debt | — | — | — | — | — | — | — | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 18,000Source | — | 3,000Source | 7,000Source | 7,000Source | — | 32,000Source | — | — | 50,000Source |
| Cost of RevenueUSD | — | — | 1,000Source | — | 1,000Source | 11,000Source | — | — | 424,000Source | — | — | — |
| Gross Profit (Calculated) · Derived | — | — | — | — | — | — | — | — | — | — | — | — |
| Selling, General and Administrative ExpenseUSD | — | — | 261,000Source | 132,000Source | 167,000Source | 246,000Source | 1,620,000Source | 248,000Source | 873,000Source | 718,000Source | 315,000Source | 325,000Source |
| Operating Income (Loss)USD | — | — | -948,000Source | -1,127,000Source | -702,000Source | -1,153,000Source | -2,289,000Source | -1,010,000Source | -4,282,000Source | -28,753,000Source | -4,028,000Source | -3,404,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -1,475,000Source | 4,241,000Source | -700,000Source | -14,352,000Source | -2,284,000Source | -1,278,000Source | -14,450,000Source | -24,737,000Source | -4,407,000Source | -7,876,000Source |
| Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | -2,580,000Source | 33,000Source | — | -621,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | -5,000Source | -6,000Source | -1,000Source | -6,000Source | 3,000Source | -11,000Source | -32,000Source | -62,000Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -1,470,000Source | 4,247,000Source | -699,000Source | -14,346,000Source | -2,287,000Source | -1,267,000Source | -11,838,000Source | -24,708,000Source | -4,407,000Source | -7,255,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.12Source | 0.37Source | -0.01Source | -1.18Source | -0.02Source | -0.11Source | -0.38Source | -2.3Source | -0.07Source | -0.1Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.12Source | 0.06Source | -0.01Source | -1.18Source | -0.02Source | -0.11Source | -0.38Source | -2.3Source | -0.07Source | -0.1Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 12,185,412Source | 11,503,955Source | 107,821,231Source | 12,185,412Source | 107,785,675Source | 12,062,743Source | 31,550,457Source | 10,757,147Source | 60,248,078Source | 70,496,041Source |
| Additional Financial Items | ||||||||||||
| Costs and ExpensesUSD | — | — | — | — | — | — | — | — | — | — | 4,028,000Source | 3,454,000Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | 288,000Source | 281,000Source | 284,000Source | 288,000Source | 285,000Source | 283,000Source | 1,145,000Source | 1,119,000Source | 1,120,000Source | 1,113,000Source |
| Goodwill, Impairment LossUSD | — | — | — | 0Source | — | — | — | — | — | 25,093,000Source | 0Source | 0Source |
| Interest ExpenseUSD | — | — | 262,000Source | 305,000Source | — | 260,000Source | — | 271,000Source | 793,000Source | 1,065,000Source | 444,000Source | 462,000Source |
| Interest Income (Expense), Nonoperating, NetUSD | — | — | 3,000Source | 3,000Source | — | 3,000Source | — | 3,000Source | 13,000Source | 13,000Source | — | — |
| Investment Income, InterestUSD | — | — | — | — | 2,000Source | 3,000Source | 5,000Source | 3,000Source | — | — | 13,000Source | 24,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | 4,247,000Source | — | — | — | — | — | — | -4,336,000Source | -7,051,000Source |
| Operating Costs and ExpensesUSD | — | — | 966,000Source | 1,127,000Source | 705,000Source | 1,160,000Source | 2,296,000Source | 1,010,000Source | 4,314,000Source | — | — | — |
| Operating ExpensesUSD | — | — | — | 1,127,000Source | — | — | — | 1,010,000Source | — | 28,753,000Source | — | — |
| Other ExpensesUSD | — | — | 109,000Source | 45,000Source | 67,000Source | 120,000Source | 67,000Source | 115,000Source | 417,000Source | 171,000Source | — | — |
| Other General ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 184,000Source | 68,000Source |
| Research and Development ExpenseUSD | — | — | 52,000Source | 82,000Source | 76,000Source | 75,000Source | 46,000Source | 103,000Source | 340,000Source | 278,000Source | 1,147,000Source | 1,226,000Source |
| Selling and Marketing ExpenseUSD | — | — | 2,000Source | 461,000Source | — | 1,000Source | 1,000Source | 19,000Source | 24,000Source | 633,000Source | — | — |
| Interest Expense (non-operating) | — | — | — | — | — | —Source | — | —Source | — | — | — | — |
| Amortization of Intangible Assets | — | — | — | — | — | — | —Source | —Source | — | — | — | — |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | — | — | — | — | — | — | — | —Source | — | — | — | — |
| Interest Expense, Debt | — | — | —Source | — | — | — | — | — | — | — | — | — |
Filing attachments
ex99-1.htm · 8-K · 2026-11-03
Exhibit 99.1 Impact Biomedical Inc. and Zoar Limited Announce SEC Declaration of Effectiveness of Form F-4 Registration Statement, Marking Major Milestone Toward Closing of Proposed Business Combination Special meeting of Impact Biomedical stockholders to approve the proposed Business Combination scheduled for November 13, 2026, at 10:00 a.m. Eastern Standard Time Upon closing, the combined company is expected to operate as Zoar Limited and trade on NYSE American under the ticker symbol “ZOAR…
Read attachment ↗ex99-1.htm · 8-K · 2026-09-17
EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Impact Biomedical Inc Announces Filing of Form F-4 Registration Statement in Connection with Proposed Merger with Zoar Limited (f/k/a Dr Ashleys Limited) Houston, Texas September 16, 2026 - Impact Biomedical Inc. (NYSE: IBO) (the “ Company ” or “ Impact ”) announced that a Form F-4 registration statement (the “ Registration Statement ”) was filed with the U.S. Securities and Exchange Commission (the “ SEC ”) on Thursday, September 10, 2026, by Zoar…
Read attachment ↗ex99-1.htm · 8-K · 2026-09-15
EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 CORRECTED - Impact Biomedical Inc (NYSE: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Limited (f/k/a Dr Ashleys Limited) Houston, Texas September 14, 2026 This corrected press release is being issued to correct the merger exchange ratio that was incorrectly stated in the press release of Impact Biomedical Inc. (the “Company” or “Impact”) dated September 11, 2026. The original press release incorrectly st…
Read attachment ↗